We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Patent Ductus Arteriosus in Preterm Neonates—Concerns With Some Recommendations

Sergio G. Golombek, MD, MPH1,2,3; Augusto Sola, MD3
[+] Author Affiliations
1Division of Newborn Medicine, Department of Pediatrics and Clinical Public Health, New York Medical College, Valhalla
2Maria Fareri Children’s Hospital at Westchester Medical Center, Valhalla, New York
3SIBEN (Iberoamerican Society of Neonatology), Dana Point, California
JAMA Pediatr. 2015;169(12):1177. doi:10.1001/jamapediatrics.2015.2789.
Text Size: A A A
Published online


To the Editor We read with interest the review article by Jain and Shah.1 It is a very detailed summary of the current management of patent ductus arteriosus in preterm neonates.1 However, we are concerned with the apparent recommendation in Figure 1 for the use of diuretics and digoxin. Bhatt and Nahata2 recommended against the use of digoxin, as its risks seem to outweigh the benefits. Furthermore, Bhatt and Nahata do not include any comments regarding furosemide. In 2008, we published the first Clinical Consensus of the Iberoamerican Society of Neonatology (SIBEN),3 where 2 recognized experts in the field (Ron Clyman, MD, University of California at San Francisco, and Bart Van Overmeire, MD, Université libre de Bruxelles) and 45 neonatologists from 23 countries were invited for active participation and collaboration. We stated there that “the use of furosemide could increase the prevalence of PDA [patent ductus arteriosus] due to its effects as a prostaglandin inhibitor.”4 Furosemide increases prostaglandin production at the renal level. Therefore, the ductus response to the pharmacologic closure treatment with prostaglandin inhibitors (indomethacin and ibuprofen) could be minimized according to randomized studies. Moreover, to our knowledge, there are no studies that report significant benefits of furosemide and none documented long term. Furosemide not only increases the prevalence of ductal patency and can inhibit indomethacin efficacy for closure, but also leads to metabolic, hydroelectrolytic, and renal risks (nephrocalcinosis), as well as hypoacusia. Therefore, based on the available literature, this consensus group did not recommend the use of diuretics and even less of furosemide at this gestational and postnatal age. In 2014, we repeated these recommendations in our Neofarma SIBEN.5


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





December 1, 2015
Prakesh S. Shah, MD, MSc, FRCPC; Amish Jain, MBBS, MRCPCH
1Department of Paediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada2University of Toronto, Toronto, Ontario, Canada
JAMA Pediatr. 2015;169(12):1177-1178. doi:10.1001/jamapediatrics.2015.2792.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...